Case Study: A method to measure anti-vaccine antibodies

26 January 2023

There is a lack of guidelines for the bioanalytical community regarding developing and validating vaccine antibody assays. In this case study, learn how the Immunogenicity Centre of Excellence team at Drug Development Solutions (DDS) followed recommendations in a recent AAPS paper (2021) to validate an antibody assay to measure anti-vaccine antibodies (AVAs).

Download PDF >>